Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Sepracoat given European Approval of Conformity Certificate

Aug. 30, 1996

Repel proved effective in preclinical studies

Aug. 23, 1996

Genzyme's Seprafilm approved by FDA

Aug. 23, 1996

Kanebo and Ontogen to codevelop cell adhesion factor inhibitor

Aug. 23, 1996

Dusa completes phase IIb for ALA PDT

Aug. 23, 1996

Dyad granted U.S. patent for oligonucleotides

Aug. 23, 1996

Protein Polymer Technologies and Ethicon sign R&D agreement

Aug. 23, 1996

Microsponge retinol system to be codeveloped by APS and Avon

Aug. 16, 1996

Phytopharm files for U.K. marketing approval of Zemaphyte

Aug. 16, 1996

Psoriasin role in psoriasis pathology under scrutiny

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...